Silvercrest Asset Management Group LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.1 Billion
- Q1 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 150,198 shares of ARWR stock, worth $3.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
150,198
Previous 100,226
49.86%
Holding current value
$3.9 Million
Previous $3.07 Million
40.08%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$399 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$322 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$222 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$171 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$108 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.75B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...